Eva Roblegg
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 34
- Advanced Drug Delivery Systems 32
- Advancements in Transdermal Drug Delivery 15
- Biomaterials 16
- Co-authors
- Eleonore Fröhlich (41 shared papers)Claudia Meindl (18 shared papers)Johannes Khinast (28 shared papers)Andreas Zimmer (23 shared papers)Gerd Leitinger (24 shared papers)Thomas Rudolf Pieber (6 shared papers)Birgit Johanna Teubl (12 shared papers)Markus Absenger (6 shared papers)
In The Last Decade
Eva Roblegg
121 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 154
- Pharmaceutical Science 1.1k
- Biomaterials 588
- Pollution 443
- Materials Chemistry 1.1k
- Health, Toxicology and Mutagenesis 310
Countries citing papers authored by Eva Roblegg
This map shows the geographic impact of Eva Roblegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Roblegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Roblegg more than expected).
Fields of papers citing papers by Eva Roblegg
This network shows the impact of papers produced by Eva Roblegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Roblegg. The network helps show where Eva Roblegg may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Roblegg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 258 | |
| 2 | 2013 | 208 | |
| 3 | 2014 | 151 | |
| 4 | 2013 | 124 | |
| 5 | 2012 | 116 | |
| 6 | 2019 | 116 | |
| 7 | 2012 | 104 | |
| 8 | 2009 | 102 | |
| 9 | 2009 | 99 | |
| 10 | 2011 | 98 | |
| 11 | 2012 | 95 | |
| 12 | 2020 | 90 | |
| 13 | 2013 | 88 | |
| 14 | 2016 | 69 | |
| 15 | 2012 | 66 | |
| 16 | 2011 | 61 | |
| 17 | 2013 | 60 | |
| 18 | 2017 | 57 | |
| 19 | 2015 | 56 | |
| 20 | 2014 | 56 |
About Eva Roblegg
Eva Roblegg is a scholar working on Pharmaceutical Science, Biomaterials, Materials Chemistry, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 3.9k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (34 papers), Advanced Drug Delivery Systems (32 papers), Nanoparticles: synthesis and applications (20 papers), Advancements in Transdermal Drug Delivery (15 papers), Inhalation and Respiratory Drug Delivery (14 papers), Crystallization and Solubility Studies (11 papers), 3D Printing in Biomedical Research (9 papers) and Microplastics and Plastic Pollution (8 papers). The work is most often cited by research in Pharmaceutical Science (1.1k citations), Biomaterials (588 citations), Pollution (443 citations), Materials Chemistry (1.1k citations) and Health, Toxicology and Mutagenesis (310 citations). Eva Roblegg has collaborated with scholars based in Austria, Germany and Croatia. Frequent co-authors include Eleonore Fröhlich, Claudia Meindl, Johannes Khinast, Andreas Zimmer, Gerd Leitinger, Thomas Rudolf Pieber, Birgit Johanna Teubl, Markus Absenger, Carolin Tetyczka and Davud B. Sirjani. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Molecular Pharmaceutics, AAPS PharmSciTech and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.